老年乳腺癌患者治疗中的心血管并发症。
Cardiovascular complications of breast cancer therapy in older adults.
机构信息
Division of Cardiology, Duke University Medical Center, Durham, North Carolina 27710, USA.
出版信息
Oncologist. 2011;16(8):1138-43. doi: 10.1634/theoncologist.2010-0348. Epub 2011 Jul 7.
Abstract
Older adults frequently have pre-existing and cancer-related risk factors for cardiovascular toxicity from cancer treatment. In this review, we discuss the risk factors and strategies for prevention and management of cardiovascular complications in older women with breast cancer.
摘要
老年人通常存在与癌症治疗相关的心血管毒性的预先存在的和癌症相关的危险因素。在这篇综述中，我们讨论了老年女性乳腺癌患者心血管并发症的风险因素和预防及管理策略。
相似文献
1
Cardiovascular complications of breast cancer therapy in older adults.老年乳腺癌患者治疗中的心血管并发症。
Oncologist. 2011;16(8):1138-43. doi: 10.1634/theoncologist.2010-0348. Epub 2011 Jul 7.
2
Mortality, leukemic risk, and cardiovascular toxicity of adjuvant anthracycline and taxane chemotherapy in breast cancer: a meta-analysis.辅助蒽环类和紫杉烷化疗在乳腺癌中的死亡率、白血病风险和心血管毒性：一项荟萃分析。
Breast Cancer Res Treat. 2012 Sep;135(2):335-46. doi: 10.1007/s10549-012-2121-6. Epub 2012 Jun 12.
3
Re: Therapy Insight: anthracyclines and trastuzumab--the optimal management of cardiotoxic side effects.关于：治疗洞察：蒽环类药物与曲妥珠单抗——心脏毒性副作用的最佳管理
Nat Clin Pract Oncol. 2008 Nov;5(11):E1. doi: 10.1038/ncponc1275.
4
Drug discovery for breast cancer and co-instantaneous cardiovascular disease: what is the future?乳腺癌与同时发生的心血管疾病的药物研发：未来何去何从？
Future Med Chem. 2013 Mar;5(4):359-62. doi: 10.4155/fmc.12.210.
5
Treatment with aromatase inhibitors and markers of cardiovascular disease.芳香化酶抑制剂治疗与心血管疾病标志物
Breast Cancer Res Treat. 2016 Nov;160(2):261-267. doi: 10.1007/s10549-016-3985-7. Epub 2016 Sep 23.
6
That an Ounce of Prevention Is Worth a Pound of Cure Is Certainly True for Patients With Breast Cancer.对于乳腺癌患者来说，一盎司的预防抵得上一磅的治疗，这一点千真万确。
J Oncol Pract. 2018 Apr;14(4):216. doi: 10.1200/JOP.18.00155.
7
Long-term chemotherapy-related cardiovascular morbidity.长期化疗相关的心血管疾病发病率
Cancer Treat Rev. 2000 Dec;26(6):429-47. doi: 10.1053/ctrv.2000.0175.
8
Cardiovascular outcomes in women with advanced breast cancer exposed to chemotherapy.接受化疗的晚期乳腺癌女性的心血管结局。
Pharmacoepidemiol Drug Saf. 2012 Aug;21(8):818-27. doi: 10.1002/pds.3239. Epub 2012 Mar 15.
9
Febrile neutropaenia and chemotherapy discontinuation in women aged 70 years or older receiving adjuvant chemotherapy for early breast cancer.70岁及以上老年女性早期乳腺癌接受辅助化疗时的发热性中性粒细胞减少症与化疗中断
Clin Oncol (R Coll Radiol). 2014 Nov;26(11):692-6. doi: 10.1016/j.clon.2014.05.002. Epub 2014 Jun 6.
10
The long-term effect of age on cardiovascular disease in patients with breast cancer who received chemotherapy.化疗后患有乳腺癌的患者年龄对心血管疾病的长期影响。
Breast Cancer Res Treat. 2020 Apr;180(3):665-674. doi: 10.1007/s10549-020-05568-8. Epub 2020 Feb 25.
引用本文的文献
1
Cardiovascular Concerns, Cancer Treatment, and Biological and Chronological Aging in Cancer: Family Series.癌症中的心血管问题、癌症治疗以及生物衰老和自然衰老：家族系列研究
JACC CardioOncol. 2024 Apr 8;6(2):143-158. doi: 10.1016/j.jaccao.2024.02.001. eCollection 2024 Apr.
2
The Predictive Role of Serum Lipid Levels, p53 and ki-67, According to Molecular Subtypes in Breast Cancer: A Randomized Clinical Study.血清脂质水平、p53 和 ki-67 对乳腺癌分子亚型的预测作用：一项随机临床研究。
Int J Mol Sci. 2024 Mar 31;25(7):3911. doi: 10.3390/ijms25073911.
3
Life-Threatening Hematoma in an Elderly Breast Cancer Patient Undergoing Chemotherapy.一名接受化疗的老年乳腺癌患者出现危及生命的血肿。
J Breast Cancer. 2023 Oct;26(5):514-518. doi: 10.4048/jbc.2023.26.e41. Epub 2023 Sep 8.
4
Breast Cancer in Geriatric Patients: Current Landscape and Future Prospects.老年患者乳腺癌：现状与未来展望。
Clin Interv Aging. 2022 Sep 28;17:1445-1460. doi: 10.2147/CIA.S365497. eCollection 2022.
5
Divergent Cardiac Effects of Angiotensin II and Isoproterenol Following Juvenile Exposure to Doxorubicin.幼年时期接触阿霉素后血管紧张素 II 和异丙肾上腺素对心脏产生的不同影响。
Front Cardiovasc Med. 2022 Mar 25;9:742193. doi: 10.3389/fcvm.2022.742193. eCollection 2022.
6
Targeted Agents for HER2-Positive Breast Cancer: Optimal Use in Older Patients.针对 HER2 阳性乳腺癌的靶向药物：老年患者的最佳应用。
Drugs Aging. 2021 Oct;38(10):829-844. doi: 10.1007/s40266-021-00889-9. Epub 2021 Aug 23.
7
Identification of Subclinical Myocardial Dysfunction in Breast Cancer Patients with Metabolic Syndrome after Cancer-Related Comprehensive Therapy.癌症相关综合治疗后代谢综合征乳腺癌患者亚临床心肌功能障碍的识别
Cardiol Res Pract. 2021 Mar 2;2021:6640673. doi: 10.1155/2021/6640673. eCollection 2021.
8
Myocardial damage assessed by late gadolinium enhancement on cardiovascular magnetic resonance imaging in cancer patients treated with anthracyclines and/or trastuzumab.心血管磁共振成像评估蒽环类药物和/或曲妥珠单抗治疗的癌症患者的心肌损伤。
Eur Heart J Cardiovasc Imaging. 2021 Mar 22;22(4):427-434. doi: 10.1093/ehjci/jeaa279.
9
Long-term cardiac-specific mortality among 44,292 acute myeloid leukemia patients treated with chemotherapy: a population-based analysis.44292例接受化疗的急性髓系白血病患者的长期心脏特异性死亡率：一项基于人群的分析。
J Cancer. 2019 Oct 15;10(24):6161-6169. doi: 10.7150/jca.36948. eCollection 2019.
10
Changes in lipid profiles during and after (neo)adjuvant chemotherapy in women with early-stage breast cancer: A retrospective study.早期乳腺癌女性新辅助化疗期间和（新）辅助化疗后的血脂谱变化：一项回顾性研究。
PLoS One. 2019 Aug 29;14(8):e0221866. doi: 10.1371/journal.pone.0221866. eCollection 2019.
本文引用的文献
1
Cardiac toxicity from systemic cancer therapy: a comprehensive review.全身癌症治疗的心脏毒性：全面综述。
Prog Cardiovasc Dis. 2010 Sep-Oct;53(2):94-104. doi: 10.1016/j.pcad.2010.05.006.
2
The compelling need for a cardiology and oncology partnership and the birth of the International CardiOncology Society.心脏病学和肿瘤学合作的迫切需求以及国际心脏病肿瘤学会的诞生。
Prog Cardiovasc Dis. 2010 Sep-Oct;53(2):88-93. doi: 10.1016/j.pcad.2010.06.002.
3
Different anthracycline derivates for reducing cardiotoxicity in cancer patients.用于降低癌症患者心脏毒性的不同蒽环类衍生物。
Cochrane Database Syst Rev. 2010 May 12;2010(5):CD005006. doi: 10.1002/14651858.CD005006.pub4.
4
Polypharmacy in older adults with cancer.老年癌症患者的多种药物治疗。
Oncologist. 2010;15(5):507-22. doi: 10.1634/theoncologist.2009-0290. Epub 2010 Apr 24.
5
Cardiac side-effects of cancer chemotherapy.癌症化疗的心脏副作用。
Int J Cardiol. 2010 Sep 24;144(1):3-15. doi: 10.1016/j.ijcard.2010.03.003. Epub 2010 Apr 18.
6
A model for the shared care of elderly patients with cancer.老年癌症患者共同照护模式。
J Am Geriatr Soc. 2009 Nov;57 Suppl 2:S300-2. doi: 10.1111/j.1532-5415.2009.02518.x.
7
Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy.蒽环类药物诱导性心肌病：临床相关性及药物治疗反应。
J Am Coll Cardiol. 2010 Jan 19;55(3):213-20. doi: 10.1016/j.jacc.2009.03.095.
8
Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention.抗癌药物的心脏毒性：需要肿瘤心脏病学和肿瘤心脏病学预防。
J Natl Cancer Inst. 2010 Jan 6;102(1):14-25. doi: 10.1093/jnci/djp440. Epub 2009 Dec 10.
9
Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy.在接受蒽环类化疗的癌症患者中降低心脏毒性的不同给药方案。
Cochrane Database Syst Rev. 2009 Oct 7(4):CD005008. doi: 10.1002/14651858.CD005008.pub3.
10
Polypharmacy in hospitalized older adult cancer patients: experience from a prospective, observational study of an oncology-acute care for elders unit.老年住院癌症患者的多重用药：一项针对老年肿瘤急症护理单元的前瞻性观察研究经验
Am J Geriatr Pharmacother. 2009 Jun;7(3):151-8. doi: 10.1016/j.amjopharm.2009.05.002.
Zotero 插件